Detalhe da pesquisa
1.
Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Clin Immunol
; 242: 109083, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908638
2.
Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro.
Transfus Med Hemother
; 49(1): 44-61, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35221867
3.
Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations.
Int J Mol Sci
; 23(15)2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955486
4.
Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.
Int J Mol Sci
; 24(1)2022 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36613907
5.
Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu).
Clin Immunol
; 217: 108467, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464186
6.
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.
Transfus Med Hemother
; 47(6): 432-443, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33442338
7.
PGE1-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood.
Int J Mol Sci
; 20(18)2019 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533251